1097802-78-2

Basic information

• Product Name: 6,7-Difluoro-2,3-dihydro-4H-1-benzothiopyran-4-one
• Synonyms: 6,7-Difluoro-2,3-dihydro-4H-1-benzothiopyran-4-one
• CAS NO: 1097802-78-2
• Molecular Formula: C₉H₆F₂OS
• Molecular Weight: 200.2051464
• Mol File: 1097802-78-2.mol

Chemical Properties

• Boiling Point: 315.1 °C at 760 mmHg
• Flash Point: 144.4 °C
• Appearance: /
• Density: 1.423
• CAS DataBase Reference: 6,7-Difluoro-2,3-dihydro-4H-1-benzothiopyran-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6,7-Difluoro-2,3-dihydro-4H-1-benzothiopyran-4-one(1097802-78-2)
• EPA Substance Registry System: 6,7-Difluoro-2,3-dihydro-4H-1-benzothiopyran-4-one(1097802-78-2)

Safety Data

• Hazardous Substances Data: 1097802-78-2(Hazardous Substances Data)

Usage

Uses

Used in Medicinal Chemistry:
6,7-Difluoro-2,3-dihydro-4H-1-benzothiopyran-4-one is utilized as a key intermediate in the synthesis of pharmaceutical compounds due to its potential biological activity. The presence of fluorine atoms and the benzothiopyran structure may contribute to its interaction with biological targets, making it a valuable component in the development of new drugs.
Used in Chemical Research:
6,7-Difluoro-2,3-dihydro-4H-1-benzothiopyran-4-one serves as a subject of study in chemical research, where its reactivity, properties, and potential applications are explored. The organofluorine nature and the fused ring system of 6,7-Difluoro-2,3-dihydro-4H-1-benzothiopyran-4-one make it an interesting candidate for understanding the effects of fluorination on molecular behavior and reactivity.
Used in Drug Design:
6,7-Difluoro-2,3-dihydro-4H-1-benzothiopyran-4-one is employed as a building block in drug design, where its structural features can be exploited to create novel molecules with desired pharmacological properties. The incorporation of this compound into drug candidates may lead to the development of more effective therapeutic agents.
Used in Material Science:
In the field of material science, 6,7-Difluoro-2,3-dihydro-4H-1-benzothiopyran-4-one may be investigated for its potential use in the development of new materials with unique properties. The organofluorine compounds are known for their stability and the possibility of tailoring their properties through molecular design, which could be applied in various material applications.

Upstream product

• 863667-96-3 3-((3,4-difluorophenyl)thio)propanoic acid 
• 60811-24-7 3,4-difluorobenzenethiol 

Relevant articles and documents

SUBSTITUTED SULFONE-CONTAINING TRICYCLIC COMPOUNDS AND USES THEREOF

The present invention relates to substituted sulfone-containing tricyclic compounds and analogues thereof which inhibit Bak-mediated apoptosis. The invention further relates to pharmaceutical compositions comprising a compound of the present invention and to methods of inhibiting a Bak-mediated apoptotic pathway and Bak-mediated apoptosis in a cell.

Synthesis and antitumor activities of a new series of 4,5-dihydro-1H- thiochromeno[4,3-d]pyrimidine derivatives

A new series of 4,5-dihydro-1H-thiochromeno[4,3-d ]pyrimidine derivatives have been designed and synthesized. The antitumor activities of the target compounds have been evaluated in vitro against two human cancer cell lines including A549 (human alveolar adenocarcinoma cell) and H460 (human lung cancer) by MTT assay. Most of the target compounds exhibited significant antitumor activities against A549 and H460 cancer cell lines. The most potent compound 4-(benzo[d][1,3]dioxol-5-yl)-8,9-difluoro-2-(4-methylpiperazin-1-yl)-4, 5-dihydro-1H-thiochromeno[4,3-d]pyrimidine (CH05) (IC50 = 0.44 μM, 3.07 μM) was 2.0 and 8.4 times more active than gefitinib (IC50 = 0.89 μM, 16.81 μM) against A549 and H460 cell lines, respectively.

Synthesis and biochemical evaluation of thiochromanone thiosemicarbazone analogues as inhibitors of cathepsin L

A series of 36 thiosemicarbazone analogues containing the thiochromanone molecular scaffold functionalized primarily at the C-6 position were prepared by chemical synthesis and evaluated as inhibitors of cathepsins L and B. The most promising inhibitors f

Dihydrobenzo(B)thiophenes and pharmaceutical compositions thereof useful as antifungals

2-Alkyl-, 2-alkenyl- and 2-alkynyl-2,3-dihydro-2-(1H-azolyl(C1 -C2)alkyl)benzo[b]thiophenes especially 2-alkyl-, 2-alkenyl- and 2-alkynyl-2,3-dihydro-3-hydroxy-2-(1H-1-imidazolylmethyl)-4-,5-,6- and 7-halobenzo[b]thiophenes and related derivatives having antifungal activity are disclosed. Pharmaceutical compositions comprising compounds of the invention and their use in treating fungal infections in susceptible hosts such as humans are also disclosed.